• 23andMe Turns Spit Into Dollars in Deal With Pfizer

    Bloomberg | 23andMe Inc., the genetic-testing startup backed by Google Inc., is sharing DNA data on about 650,000 individuals with Pfizer Inc., to help find new targets to treat disease and to design clinical trials.

    Jan 12, 2015

  • Chinese Services Group WuXi Buys NextCODE Health for $65m

    Bio-IT World | WuXi PharmaTech headquartered in Shanghai has acquired NextCODE Health of Iceland for $65 million in cash. The acquisition will merge the WuXi Genome Center with NextCODE to form WuXi NextCODE Genomics.

    Jan 9, 2015

  • The What and Why on 2014s Record High Drug Approvals

    Forbes | 2014 saw the highest number of new drug applications approved by FDA since 1996, but John LaMattina argues that the year was even more successful than that.

    Jan 8, 2015

  • New Antibiotic Discovered in Dirt

    New York Times | Researchers yesterday announced a new antibiotic found in dirt. Teixobactin has not been tested in humans, but was extremely effective in animal tests.

    Jan 8, 2015

  • Novartis Deal Signals Big Pharma's Entrance in CRISPR-Based Therapies

    Bio-IT World | Novartis today became the first big pharma company to announce a CRISPR program, through a deal with Intellia Therapeutics and Caribou Biosciences that will cover CAR-T therapies and hematopoietic stem cell programs.

    Jan 7, 2015

  • 2014's Turning Points in Genomics

    Bio-IT World | The $1,000 genome, CRISPR gene therapies, nanopore sequencing, the fall of 23andMe's health service... we look back at six of our most popular stories of 2014, and reflect on how each has developed since.

    Jan 7, 2015

  • Moderna's $450m Investment Brings Funding Total to $950m

    Bio-IT World Roundup | Moderna Therapeutics closed a massive private investment round earlier this week, raising $450 million bringing their total funding to $950 million.

    Jan 7, 2015

  • 23andMe Solidifies Business Model with Big Genentech Partnership

    Forbes | 23andMe has signed a deal with Genentech to sequence the whole genomes of 3,000 Parkinson's patients and relatives in its customer community, sharing both genetic and clinical data with the big biotech.

    Jan 6, 2015

  • David Mittelman Joins Tute Genomics

    Bio-IT World | David Mittelman, co-founder of Arpeggi and GCAT, the Genomics Comparison and Analytic Testing (GCAT) platform, has joined Tute Genomics as CSO.

    Jan 6, 2015

  • Promising Gene Therapy Company Spark Therapeutics to Go Public

    FierceBiotech | Spark Therapeutics, a company with a strong Phase III drug candidate bidding to be the first gene therapy approved for use in the U.S., has filed for an IPO, planning to sell $86 million in public shares.

    Jan 5, 2015

  • With FDA Recommendation, Novartis Heads for First Approval of a Biosimilar

    Reuters | In advance of a final decision to be handed down January 7, the FDA today revealed that staff reviewers have recommended approval of a biologic made by Novartis that imitates Amgen's off-patent Neupogen.

    Jan 5, 2015

  • Quanterix Aims for Early Clinical Adoption with High-Throughput Protein Assays

    Bio-IT World | Looking to open its highly sensitive Simoa instruments to new customers, Quanterix is opening an accelerator in its Massachusetts lab, where users can test out homebrewed assays in search of new biomarker tests that detect proteins at extremely low concentrations.

    Jan 2, 2015

  • Banner Year for New Drug Approvals

    Reuters | 2014 was a banner year for drug approvals, Reuters reports. 41 novel medications were approved, the most since the all-time high of 53 approvals in 1996.

    Jan 2, 2015

  • High-Performance Computing Can Accelerate Life Sciences Discoveries

    Bio-IT World | Inside the Box | As petascale supercomputing systems grow more accessible, there is now an opportunity for life sciences researchers to run computations on genomic or molecular data that would be impossible with desktops or small clusters — but only if they are willing to adapt their informatics tools to new computing architectures.

    Dec 31, 2014

  • November and December News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including a study of attitudes toward newborn genomic testing, and Definiens' latest tissue quantification software.

    Dec 30, 2014

  • Retraction Watch's Top Retractions of 2014

    The Scientist | Adam Marcus and Ivan Oransky, the founders of the Retraction Watch blog, offer their annual list of the year's most prominent, spectacular, or telling retractions in the scientific literature.

    Dec 29, 2014

  • Reindeer and 23andMe

    More Intelligent Life | One woman's search for family history led her to 23andMe first, and the reindeer next.

    Dec 24, 2014

  • Nanopore Sequencing Is Here to Stay

    Bio-IT World | Oxford Nanopore has created the world's first functional nanopore sequencer, the pocketsize MinION. As early access users start to share their experiences with the instrument, a picture is emerging of a world where DNA data could be gathered anywhere, anytime — and by almost anyone.

    Dec 22, 2014

  • The Best and Worst in a Tumultuous Year for Science

    WIRED | It's been a roller-coaster year for science. It started with what looked like a remarkable breakthrough in stem cell science, which was soon followed by a stunning announcement by cosmologists: the first detection of gravitational waves, direct evidence for a popular theory of how the universe began. But as the year draws to a close, the first of these discoveries has been thoroughly discredited, and the second appears to be on the ropes.

    Dec 22, 2014

  • Roche Acquires Bina Technologies’ Powerful Genome Analysis Platform

    Bio-IT World | Bina Technologies announced this morning that it has been acquired by Roche. Financial details were not disclosed. The Roche acquisition is, “the best outcome that could have happened for our company,” co-founder and CEO Narges Bani Asadi told Bio-IT World today.

    Dec 19, 2014